Pharmaceutical Press Releaseshttp://www.pharmiweb.com/Press Releases in the Pharmaceutical Industry. News, Jobs and Resources at PharmiWeb.comen-gb&#169; 1998 - 2010 PharmiWeb Solutions - All Rights ReservedSat, 12 Mar 2010 01:00:00 GMTPharmiWeb.comhttp://www.pharmiweb.com/images/logos/pweb_logo.gifhttp://www.Pharmiweb.com20http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17954Tranzyme Pharma’s Clinical Results on Ulimorelin (TZP-101) Selected for Oral Presentation at the Distinguished Abstract Plenary Session of Digestive Disease Week 2010<strong>Tranzyme Pharma’s Clinical Results on Ulimorelin (TZP-101) Selected for Oral Presentation at the Distinguished Abstract Plenary Session of Dig...<br />Tranzyme Pharmahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17954Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17953ERT Launches Centralized Cardiac Safety 2.0: A Revolutionary New Approach to ECG Management in Clinical Trials<strong>ERT Launches Centralized Cardiac Safety 2.0: A Revolutionary New Approach to ECG Management in Clinical Trials</strong><br />Media Contacts: ...<br />ERThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17953Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17952Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer<strong>Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer</strong><br /> Genentech, Inc., a wholly owned ...<br />Genentech Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17952Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17951Robbins Umeda LLP Announces Investigation of Medivation, Inc.<strong>Robbins Umeda LLP Announces Investigation of Medivation, Inc.</strong><br />Robbins Umeda LLP has commenced an investigation into possible br...<br />Robbins Umeda LLPhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17951Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17950Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Medivation, Inc., Announces Class Action Lawsuit and Seeks to Recover Losses<strong>Glancy Binkow &amp; Goldberg LLP, Representing Investors Who Purchased Medivation, Inc., Announces Class Action Lawsuit and Seeks to Recover L...<br />Glancy Binkow &amp; Goldberg LLPhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17950Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17948AVEO Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering<strong>AVEO Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering</strong><br /> AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopha...<br />AVEO Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17948Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17947Medtronic Announces Public Offering of Senior Notes<strong>Medtronic Announces Public Offering of Senior Notes</strong><br /> Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.25 ...<br />Medtronic Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17947Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17946Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader<strong>Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader</strong><br /> Emergent BioSoluti...<br />Emergent BioSolutions Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17946Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17945Akorn, Inc. Enters into an Agreement to Sell Common Stock and Warrants<strong>Akorn, Inc. Enters into an Agreement to Sell Common Stock and Warrants</strong><br />Akorn, Inc. (NASDAQ: AKRX) a niche generic pharmaceutical...<br />Akorn Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17945Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17944Williams Love O’Leary & Powers Represent Local Women Who Say Breast Cancer Was Preventable<strong>Williams Love O’Leary &amp; Powers Represent Local Women Who Say Breast Cancer Was Preventable</strong><br /> Attorney Mike Williams announced...<br />Williams Love O’Leary &amp; Powershttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17944Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17943Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu Vaccine<strong>Baxter Presents Clinical Efficacy Results from Phase III Study of Seasonal Flu Vaccine</strong><br /> Baxter International Inc. (NYSE:BAX), in...<br />Baxter International Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17943Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17942ASBMR Task Force Reviewing Link Between Fractures and Bisphosphonate Therapy<strong>ASBMR Task Force Reviewing Link Between Fractures and Bisphosphonate Therapy</strong><br /> Recent reports suggesting a link between long-term...<br />ASBMRhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17942Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17940Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer<strong>Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer</strong><br /> Pfiz...<br />Pfizer Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17940Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17939Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary Endpoint<strong>Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary Endpoint</strong><br /> P...<br />Pfizer Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17939Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17938NPS Pharmaceuticals Reports 2009 Results and 2010 Outlook<strong>NPS Pharmaceuticals Reports 2009 Results and 2010 Outlook</strong><br /> NPS Pharmaceuticals, a specialty pharmaceutical company developing i...<br />NPS Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17938Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17937Bioject to Report Fourth Quarter and Year-End 2009 Financial Results<strong>Bioject to Report Fourth Quarter and Year-End 2009 Financial Results</strong><br /> Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading...<br />Bioject Medical Technologies Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17937Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17936Del Global Technologies Reports Fiscal 2010 Second Quarter Financial Results<strong>Del Global Technologies Reports Fiscal 2010 Second Quarter Financial Results</strong><br />Del Global Technologies Corp. (OTCBB: DGTC) (“Del G...<br />Del Global Technologies Corp.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17936Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17935Murad Launches White Brilliance Line to Effectively Lighten and Even Skin Tone<strong>Murad Launches White Brilliance Line to Effectively Lighten and Even Skin Tone</strong><br /> Murad, Inc. has announced the launch of its new ...<br />Murad Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17935Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17934PURE Bioscience Reports Second Quarter Financial Results<strong>PURE Bioscience Reports Second Quarter Financial Results</strong><br />PURE Bioscience (NASDAQ:PURE), creator of the patented silver dihydrog...<br />PURE Biosciencehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17934Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17933“Consciousness” at 9th Annual International Bioethics Forum in Madison, Wisconsin<strong>“Consciousness” at 9th Annual International Bioethics Forum in Madison, Wisconsin</strong><br /> The 9th Annual International Bioethics Forum...<br />BioPharmaceutical Technology Center Institutehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17933Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17932Celldex Therapeutics to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference<strong>Celldex Therapeutics to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference</strong><br /> Celldex Therapeutics, Inc. ...<br />Celldex Therapeutics Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17932Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17931Therapy Guidance for Patients with Colorectal Cancer Discussed at NCCN Annual Conference<strong>Therapy Guidance for Patients with Colorectal Cancer Discussed at NCCN Annual Conference</strong><br /> Despite statistics stating that colore...<br />NCCNhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17931Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17930Neoprobe to Hold Lymphoseek Update Call<strong>Neoprobe to Hold Lymphoseek Update Call</strong><br /> Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology sur...<br />Neoprobe Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17930Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17929Maxygen Reports Fourth Quarter and Year End 2009 Financial Results<strong>Maxygen Reports Fourth Quarter and Year End 2009 Financial Results</strong><br /> Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company foc...<br />Maxygen Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17929Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17928Neoprobe Announces Successful Meeting on Lymphoseek Phase 3 Results<strong>Neoprobe Announces Successful Meeting on Lymphoseek Phase 3 Results</strong><br /> Neoprobe Corporation (OTCBB: NEOP), a diversified developer...<br />Neoprobe Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17928Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17927Cleantech Goes Mainstream at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010<strong>Cleantech Goes Mainstream at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010</strong><br /> ROTH Capital Partne...<br />ROTH Capital Partnershttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17927Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17926Advaxis Develops Room Temperature Formulation of ADXS11-001<strong>Advaxis Develops Room Temperature Formulation of ADXS11-001</strong><br />Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocy...<br />Advaxis Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17926Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17925Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders<strong>Ipsen Grants Rhythm Exclusive Worldwide License for Two Programs in the Field of Metabolic Disorders</strong><br /> Regulatory News: Ipsen (...<br />Ipsenhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17925Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17924Research and Markets: Systemic Fungal Infection Therapeutics Market in Australia<strong>Research and Markets: Systemic Fungal Infection Therapeutics Market in Australia</strong><br />Research and Markets (http://www.researchandmar...<br />Research and Markets Ltd.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17924Sat, 12 Mar 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17923Agios Pharmaceuticals Appoints William Kaelin Jr., M.D. to Scientific Advisory Board<strong>Agios Pharmaceuticals Appoints William Kaelin Jr., M.D. to Scientific Advisory Board</strong><br /> Agios Pharmaceuticals, the leading biophar...<br />Agios Pharmaceuticalshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=17923Sat, 12 Mar 2010 01:00:00 GMT